focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 191.00
Bid: 190.00
Ask: 192.00
Change: 0.50 (0.26%)
Spread: 2.00 (1.053%)
Open: 191.00
High: 192.00
Low: 191.00
Prev. Close: 190.50
FRAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Franchise Brands plc

17 Feb 2022 15:45

RNS Number : 0493C
Dowgate Capital Limited
17 February 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Dowgate Wealth Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Franchise Brands plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Exempt fund manager connected to Franchise Brands plc

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16/02/2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

987,301

1.0299%

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

987,301

1.0299%

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary shares

purchase

 

32,500

£1.45

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

17/02/2022

Contact name:

Colin Johnson

Telephone number*:

02039037724

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUBAVRUBUUAAR
Date   Source Headline
28th Oct 20202:01 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSQ3 Trading Update
28th Sep 20207:00 amRNSDirector shareholdings, issue of equity & TVR
22nd Sep 20207:00 amRNSDirector/PDMR Shareholding
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
16th Sep 20207:00 amRNSGrant under New Share Option Scheme, PDMR Dealings
30th Jul 20207:00 amRNSInterim Results
7th Jul 20207:00 amRNSNotice of Results
1st Jul 20207:00 amRNSShare purchase programme and EBT
30th Jun 20205:00 pmRNSTotal Voting Rights
25th Jun 20207:00 amRNSExercise of Options and Other Matters
9th Jun 20204:00 pmRNSDirectors’ shareholdings
3rd Jun 20207:00 amRNSResult of scrip dividend and change to TVR
22nd May 20204:42 pmRNSHolding(s) in Company
1st May 20205:10 pmRNSHoldings in Company and director’s holding
30th Apr 20205:00 pmRNSTotal Voting Rights
30th Apr 202010:40 amRNSHolding(s) in Company
29th Apr 20209:00 amRNSHolding(s) in Company
28th Apr 20203:05 pmRNSHolding(s) in Company
28th Apr 202011:19 amRNSResult of Annual General Meeting
28th Apr 20208:30 amRNSHoldings in Company and director’s holding
27th Apr 202012:00 pmRNSHolding(s) in Company
21st Apr 202012:44 pmRNSResult of Bookbuild
20th Apr 20204:38 pmRNSProposed Placing and Trading Update
7th Apr 20207:00 amRNSBoard & senior management scrip dividend election
30th Mar 20207:00 amRNSTrading and dividend update, notice of AGM
12th Mar 20203:46 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
6th Mar 20204:52 pmRNSHolding(s) in Company
5th Mar 20202:17 pmRNSExercise of share options & total voting rights
5th Mar 20207:00 amRNSFinal Results
15th Jan 20207:00 amRNSTrading Update and Notice of Annual Results
2nd Jan 202010:40 amRNSShare Repurchase Programme
2nd Jan 20209:39 amRNSShare Repurchase Programme
29th Nov 20195:00 pmRNSTotal Voting Rights
25th Nov 20193:49 pmRNSExercise of options and change to TVR
12th Nov 201910:02 amRNSDirector/PDMR Shareholding
31st Oct 20195:00 pmRNSTotal Voting Rights
29th Oct 20197:00 amRNSFranchise Brands plc to present at Mello London
7th Oct 20197:00 amRNSAcquisition and Trading Update
5th Sep 20193:30 pmRNSHoldings in Company
2nd Sep 20198:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSTRANSACTION IN OWN SHARES
28th Aug 20197:00 amRNSPDMR Shareholding and change to voting rights
20th Aug 20194:36 pmRNSShare Buyback Programme
13th Aug 20197:00 amRNSDirector/PDMR shareholding
7th Aug 20194:00 pmRNSTransaction in Own Shares
6th Aug 20197:00 amRNSTransaction in Own Shares
5th Aug 20193:13 pmRNSTransaction in Own Shares
5th Aug 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.